Real-world efficacy and safety profile of four JAK inhibitors in rheumatoid arthritis: a French single-center observational study

Study limitation reported by the research below: “Filgotinib was prescribed exclusively to women in this cohort due to early spermatogenesis concerns, limiting the generalizability of its effectiveness and persistence data to male patients.”